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The accumulated evidence indicates that liberation of a proteolytic enzyme 
from its inactive precursor plays a  part  in anaphylactic and anaphylactoid 
processes (1-5). It is well known that fibrinolysin (also called plasmin, serum 
protease, and serum tryptase) is inactivated by an inhibitor present in serum 
(antitibrinolysin,  antiplasmin, antiprotease, antitryptase). 
The observations reported  in the present paper  indicate that  the  rate  of 
inactivation  of fibrinolysin  by antitibrinolysin  is controlled by the pituitary and 
the adrenal cortex and they suggest that this action is mediated by the spleen. 
Methods and Materials 
Activation of profibrinolysin was induced by a procedure described previously (5). To 2 
ml. of guinea pig serum 0.4 ml. of a 10 per cent peptone ~  solution was added. After 2 minutes' 
contact,  the mixture was diluted to 48 ml. with distilled water and adjusted to pH 5.2 with 
0.S per cent acetic acid to precipitate  the euglobulin fraction which contains fibrinolysin. 
After centrifugation, the precipitate was redissolved in saline buffered at pH 7.4 (phosphate 
buffer diluted to 0.1 M with 0.85 per cent NaCI solution). This solution made up to 1.5 ml. 
was warmed up to 37.$°C. and pipetted into an Ostwald viscosimeter containing 2 ml. of a 3 
per cent solution of gelatin placed in a constant temperature bath (37.5°C. 4- 0.05). Flow  times 
were measured 4 to 6 times during 20 minutes. Further details of the technique, calculations, 
definition of the unit and the standardization  curve used in this study were reported in a 
previous publication ($). Results of these experiments are expressed as units of fibrinolysin 
released by mi. of serum. 
Antifibrinolysin activity of serum was estimated by a similar technique. Purified fibrinolysin 
was prepared according to the method of Loomis, George, and Ryder (6).  ~ Fibrinolysin dis- 
solved in buffered saline and kept at --30°C. for several days lost its activity slowly. Before 
using it for antifibrinolysin estimation  the enzyme solution was standardized  every day. 
Amounts corresponding to 8 to 10 units were then mixed with 25 #1. of the serum to be tested. 
* This work was supported  in part by a  research grant from the United States  Public 
Health Service. 
i Proteose peptone Difco. 
2 Part of the work was done with fibrinolysin kindly supplied by Mr. E. C. Loomis of the 
Research Laboratories, Parke, Davis and Company. 
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The volume was made up to 1.5 ml. with saline. Mter contact for 5 minutes the mixture of 
enzyme and serum was pipetted into the viscosimeter which contained the gelatin. The effect 
of this mixture on viscosity was determined as described in the previous paragraph. The number 
of units inhibited was obtained by subtracting the potency of the fibrinolysin-serum mixture 
from that of fibrinolysin alone. 
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FIG. 1.  Inhibition of fibrinolysin by guinea pig serum after 5 minutes' contact. Abscissa: 
units of fibrinolysin inhibited; Ordinate:/~1.  of guinea pig serum (log scale). 
Fig. 1 shows a linear relationship between the number of units of fihrinolysin inhibited and 
the concentration of serum when the latter is plotted on a logarithmic scale.  When 25/~1. of 
sem.m did not cause inactivation or did inactivate all the fibrinolysin, smaller or larger amounts 
were tried. Results are expressed  in units of fihrinolysin inactivated by 25/A. of serum. As it 
is not certain that the linear relationship is valid for amounts of serum higher than 60/~1., 
extrapolation for 1 ml. did not seem to be justified. 
Blood was collected from guinea pigs by heart puncture and allowed to clot. The serum 
was then used either immediately after separation from the clot or within 48 hours. In the 
latter case the ~erum was kept frozen at --30°C. In experiments with rats, the animals were 
decapitated and bled through the vessels of the neck. 
Anterior pituitary,  adrenocortical,  and  splenic substances  were injected subcutaneously 
and blood samples were taken at stated intervals after treatment. 
EXPERIMENTAL 
Action of Adrenocorticotroph~c Hormone  (ACT/t) and Cortisone on Activation 
of Profibrinolysin.wWhen the activation of profibrinolysin by peptone  in sere 
of guinea pigs treated with ACTH s and  cortisone  4 was compared with that  in 
3 ACTH, Lot 57A potency 250 per cent, kindly supplied by Dr. John R. Mote of Armour 
and. Company. 
4 Saline suspension  of cortisone acetate 2.5 per cent kindly supplied by Dr. J. M. Carlisle 
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sera of normal guinea pigs no significant differences were found. In a previous 
study (5), eight guinea pig sera activated with peptone showed a mean release 
of 4.95 4- 0.94 units of fibrinolysin per ml. as measured by the fibrinogenolyfic 
method. Using  the viscosimetric method the sera of five normal guinea pigs 
showed 5.6 :t: 0.35 units of fibrinolysin.  1 hour after injection of 50#g. ACTH 
in eight guinea pigs, the serum fibrinolysin was 5.15 4- 0.76 units. 3 hours after 
TABLE I 
Antifibrinolytic Power of Sera  from Guinea Pigs Treated ~vith A CTH and Adrenocortical 
Hormones 
Substance 
Normal guinea pigs 
ACTH 
Cortisone acetate 
Desoxycor  ticosterone  acetate 
Corficosterone 
Corticosterone  acetate 
Dose per kg. 
lpg. 
5pg. 
20 ~g. 
20 vg. 
1 rag. 
1 nag. 
1 rag. 
1 rag. 
10 rag. 
10 rag. 
1 rag. 
5 rag. 
5 rag. 
0.6 rag. 
2  rag. 
2 rag. 
Units fibrino- 
al  iysin inhibited 
Ial  I  per 2s i.d. 
--  ° 
1  4.7 
1  6.4 
1  10.1 
2  7.3 
2  8.2 
4  7.2 
6  6.0 
3  6.8 
1  7.4 
5  8.9 
2  4.6 
1  4.4 
5  4.5 
3  4.6 
1  5.0 
5  4.8 
No. of 
animals 
17 
injection of 10 rag. of cortisone acetate in five guinea pigs the fibfinolysin re- 
lease was 5.2  -4- 0.86 units. These observations indicate that neither of these 
hormones influences the amount of fibrinolysin liberated from profibrinolysin 
by the addition of peptone to serum. 
Action of ACTH and Adrenocortical Hormones on Fibrinolysin Inaaivation.-- 
In seventeen guinea pigs the mean antifibrinolytic action of serum was 4.7 4. 
0.40 units per 25/~1. Estimation of antifibrinolytic activity in the serum of ani- 
mals injected with ACTH and cortisone shows an increase which was statisti- 
cally highly significant. Twenty-five guinea pigs were injected subcutaneously 92  ]~IBRINOLYSIS AND  HORMONES 
with varying amounts of ACTH and it is seen in Table I  that 20/~g./kg.  of 
ACTH produces a  significant rise in antifibrinolytic activity. The maximum 
effect appears to be reached within 1 hour after injection and then decreases 
rapidly. In contrast, the effect of cortisone acetate increases with time. This 
difference is probably due to the fact that ACTH dissolved in saline reaches the 
circulation rapidly while cortisone in suspension is absorbed slowly. Table I 
shows the effect of cortisone acetate in ten guinea pigs and it is also seen that 
neither desoxycorticosterone acetate,  5 nor corticosterone  6 shows  any activity 
at the dosages employed. 
Table II shows that the action of ACTH is mediated through the adrenals. 
Whereas 50/~g. of ACTH increased significantly the antifibrinolytic power of 
TABLE II 
Antifibrinolyti~, Power of the Serum of Normal and Adrenalectomized Rats Treated with ACTH 
Substance 
Normal rats 
ACTH 
Adrenaleetomized  rats 
ACTH 
Dose per kg. 
m 
10 ~g. 
50 ~g 
50 t~g 
1 
1 
1 
Units fibrino- 
lysin inhibited 
per 25 ul. 
$eruH1 
2.3 
5.1 
5.25 
3.05 
2.9 
~=S.E. 
0.3 
0.66 
0.92 
0.23 
0.38 
No. of 
animals 
4 
4 
.6 
serum in six intact rats, 50 #g. of the hormone failed to produce any effect in 
four adrenalectomized rats which were maintained on NaCi. 
Action  of the Spleen.--Earlier  studies have shown that the spleen produces 
two substances, splenin A and splenin B.  Splenin A decreases capillary permea- 
bility,  increases  capillary  resistance,  and  shortens  bleeding  time;  whereas 
splenin B exerts the opposite effect in these tests. Splenin A is probably a deriva- 
tive of ascorbic acid (7). Splenin B, as recent work at this Institute by Dr. S. A. 
Karjala has shown, is an ester of two or three fatty acids with a complex alcohol. 
Normal spleen produces much less splenin B  than splenin A;  the ratio being 
about  1:1,000.  This ratio is, however, reversed in certain experimental con- 
ditions (thyroidectomy, scurvy) in which an excess of splenin B has been found 
in the spleen and in blood. 
Splenin A is released into the circulation under the influence of the pituitary 
and adrenal cortex (8). Experimental data suggested that certain actions of the 
adrenal cortical hormones, especially those concerned with capillary function, 
s DOCA, Roche-Organon,  0.5 per cent solution in peanut oil. 
6 Kindly supplied by Dr. T. Reichsteln of Basle. G.  UNGAR  AND  E.  DAMGAARD  93 
might be mediated by splenin A (7). Experiments were performed therefore on 
splenectomized guinea pigs to determine whether the presence of the spleen was 
required for the action of ACTH and cortisone on fibrinolysin inactivation. 
Table III shows that splenectomy does not alter significantly the ability of 
serum to inactivate fibrinolysin. However, when ACTH and cortisone were 
injected in splenectomized guinea pigs, their serum failed to show any increase 
in antifibrinolysin. 
TABLE 1TI 
AnHfibrinolyffc  Power of Sera from  Splenectomized Guinea  Pigs  Treated wilh  ACTH  and 
Corgsone 
Normal guinea pigs 
Splenectomized guinea pigs 
ACTtt 
Cortisone acetate 
Dose per kg. 
m 
10 ~,g. 
10 mg. 
Units fibfino- 
lysin inhibited  Int,  al  per 25 ~1. 
serum 
h 
-  4.7 
4.3 
4.5 
4.3 
:t:S,E. 
0.40 
0.19 
0.18 
0.20 
NO.  of 
animals 
17 
7 
7 
6 
TABLE IV 
Antif~rinolyg¢ Power of Sera flora Guinea Pigs  Treated u,  ith  Splenin A 
Normal controls 
Splenin A 
Splenectomized guinea  pigs 
Splenin A 
Dose per kg. 
10 pg. 
1 ~g. 
1 pg. 
Units fibrlno- 
lysin inhibited 
per 25 ~1. 
serttnl 
4.7 
9.3 
6.8 
:kS.E. 
0.40 
0.16 
0.46 
4.3 
6.8 
0.19 
0.26 
No. of ~mimnis 
17 
5 
5 
Blood samples were taken 1 hr. after subcutaneous  injection of splenin A. 
Splenin A, prepared according to the method described previously (7)  was 
injected subcutaneously into ten normal and four splenectomized guinea pigs. 
As shown in Table IV this substance produced a  significant increase in anti- 
fibrinolytic activity. An increase was observed with  1 #g./kg.  and an even 
greater increase with 10 pg./kg. It is also seen that the action of splenin A is not 
abolished by splenectomy. 
Various concentrations of splenin B 7  were injected into twenty-nine guinea 
Crystalline splenin B  was prepared  by Dr.  S. A. Karjala from a  crude extract  kindly 
supplied by Dr. E. Kaiser and Dr. R. T. Rapala of Armour and Company. 94  ~'IBRINOLYSIS  AND  HORMONES 
pigs. Table V shows that amounts as low as I0  -~ mg. reduced the antifibrino- 
lytic activity by about 25 per cent. By using larger amounts of splenin B  it 
was possible to produce statistically significant effects, confirming the  trend 
observed when small amounts were  given.  The  extremely high  activity of 
splenin B  was also observed in other tests (7). 
TABLE  V 
Antifibrinolytic Power of Sera from Gcinea Pigs Treated wi~h Splo~in B 
Normal controls 
Splenin B 
Units fibrinolysin 
Dose  per kg.  inhibited per 25 ~I.  d:S.E.  No. of animals 
serum 
--  4.7  0.40  17 
10  -n rag. 
10  -9 mg. 
2.5  X  10-  8 rag. 
2  X  10-  7 rag. 
2  X  10  4  mg. 
3.4 
2.5 
2.0 
2.3 
2.7 
0.64 
0.49 
0.30 
0.23 
0.40 
4 
5 
5 
10 
5 
Blood samples were taken 1 hr. after subcutaneous  injection  of splenin B. 
DISCUSSION 
These  observations  deal  with  the  antifibrinolytic power  of  serum  under 
specified conditions (namely after 5 minutes' incubation with fibrinolysin) and 
not with the actual antifibrinolysin content of serum. Recent work (9, 10) indi- 
cates that complete combination between fibrlnolysin and antifibrinolysin in 
ritro requires prolonged contact. With guinea pig serum an incubation of at 
least 20 minutes is necessary to reach equilibrium between the two components 
and the complex they form. It is certain, therefore, that estimation after a con- 
tact of 5 minutes does not indicate the total antifibrinolysin present.  It sup- 
plies, however, an estimate of the rapidly available antifibrinolysin. It seems 
probable that the observed action of these hormones consists in accelerating 
the combination between the enzyme and its inhibitor. This is illustrated by 
Fig. 2, which shows the amount of fibrinolysin inactivated after varying inter- 
Vals of incubation by sera pooled from five normal guinea pigs and from five 
guinea pigs treated with 10 rag. of cortisone. It is seen that although after 20 
minutes' contact both sera have inactivated all the available fibrinolysin, the 
rate of the reaction between the enzyme and the inhibitor is entirely different. 
In the serum of control animals the antifibrlnolytic action rises slowly; whereas 
in the serum of animals treated with cortisone 66 per cent of the final value is 
reached in 1 minute. 
These observations indicate that the substances concerned act by catalyzing 
the combination between fibrinolysin and its inhibitor although they may not G.  "ONGAI~.  AN]()  E.  DAMGAA.RD  95 
increase the actual amount of antifibrinolysin in serum. The rate of inactivation 
cannot be determined by the methods usually employed for the estimation of 
antifibrinolysin because these include either an unspecified time of contact or 
a maximal one. The use of trypsin instead of fibrinolysin further complicates 
the interpretation because the kinetics of the serum inactivation of trypsin and 
fibrinolysin are different (11). 
Previous studies have shown that presence of the spleen is required for certain 
functions of the adrenal cortex: in splenectomized animals cortical hormones 
do not act on capillary permeability (7) and do not alter lymphocyte and neu- 
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FIG. 2. Inhibition of fibrinolysin  by serum from normal guinea pigs and from guinea pigs 
treated with 10 rag. cortisone acetate 3 hours previously in function of the time of contact 
between enzyme  and serum.  Abscissa: time of contact  at 37.5°C.; Ordinate:  units of fibrinolysin 
inhibited per 25/zl. of serum. 
trophile counts (12, 13). There are also indications that the spleen may take 
part in fibrinolysin inactivation; for example, Macfarlane has observed that the 
spleen, of all organs, has by far the highest antifibrinolytic power (14). 
The available evidence indicates that the spleen reacts to an adrenocortical 
stimulus by releasing only splenin A with the exclusion of splenin B (8, 7). The 
mechanism by which splenin B  is liberated is at present unknown, but there 
is some evidence that the thyroid gland may be involved in it, Normally the 
spleen synthesizes very little splenin B; however this can be increased by creat- 
ing a  vitamin C  deficiency (7).  Current studies show that the production of 
splenin B can also be enhanced by applying stimuli which increase the secretion 
of thyrotrophic hormone from the pituitary. 
It seems improbable that the splenins A and B affect directly the kinetics of 96  ~IBRINOLYSIS  AND  HORMONES 
the fibrinolysin-antifibrinolysin  system. In certain in vitro experiments it was 
possible to obtain an acceleration of the fibrinolysin-antifibrinolysin reaction 
by splenin A  and its retardation  by splenin B  (7).  However, when purified 
fibrinolysin and antifibrinolysin were used, the rate of their combination was 
not changed by either substance. This suggests that the presence of some factor 
in serum is necessary to obtain this effect from the spleen substances. The na. 
ture of this intermediate reaction is being investigated. 
In view of the probable part played by fibrinolysin in shock (15-18), and 
in anaphylactic and anaphylactoid reactions (1-5), the rate of inactivation of 
the enzyme liberated under these conditions is highly important. The damage 
which fibrinolysin  can produce, either directly by attacking tissues, especially 
the capillary waU, or indirectly by releasing  histamine or other toxic protein 
breakdown products, is a function of the interval during which it circulates in 
an active form. It was found in 1944 that ACTH and adrenocortical extracts 
inhibited the release  of histamine-like  substances from blood ceils  (19).  This 
inhibition can be explained by the fact that in animals treated with these hor- 
mones fibrinolysin  is inactivated more rapidly than in normal animals. 
In the light of certain observations histamine seems to be released as a result 
of a proteolytic process (20-22). The amount of histamine liberated is therefore 
probably related to the interval during which fibrinolysin is free. These influ- 
ences are probably most effective in slow reactions like the Arthns or Shwartz- 
man phenomenon or other local sensitization reactions. It seems unlikely that 
they play any part in acute anaphylactic shock in which profibrinolysin activa- 
tion is produced rapidly and fibrinolysin exerts its effect before inactivation 
can even begin. 
That the adrenal cortex controls resistance to stress and plays the principal 
part in the "general adaptation syndrome" of Selye (23),  is recognized.  Fur- 
thermore, it has already been suggested (16) that a release of fibrinolysin is part 
of the "alarm reaction" which precedes the adaptation phase. It now appears 
that the rate of the reaction between fibrinolysin and its inhibitor may play a 
role  in the resistance to various noxious  stimuli which is usually associated 
with  augmented adrenocortical function. 
sux~a~Y 
Injection of ACTH or cortisone has no effect on the amount of fibrinolysin 
resulting from the activation of profibrinolysin by peptone. 
AntifibrinoiytiC  activity of serum is significantly  increased by ACTH or cor- 
tisone but not by desoxycorticosterone or corticosterone. No increase in anti- 
fibrinolytic power of serum is produced, however, by the injection of ACTH or 
cortisone in splenectomized guinea pigs. 
Splenin A has the same action on fibrinolysin  inactivation as ACTH or corti- 
sone.  Splenin B has the opposite effect. O. UNGAR  AND  E. DAMGAARD  97 
This action on the antifibrinolytic power of serum appears to be due to an 
acceleration of the rate of combination between the enzyme and its inhibitor 
and not to an actual increase in antitibrinolysin. 
The possible significance of these observations is discussed. 
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